PPARα signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells-Reference-Cited by-同舟云学术

PPARα signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells

Published:2009-05 Issue:9 Volume:77 Page:1480-1486
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Tuller Erin R.,Brock Andrea L.,Yu Haijun,Lou Jessica R.,Benbrook Doris M.,Ding Wei-Qun

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference51 articles.

1. Overcoming limitations of natural anticancer drugs by combining with artificial agents;Blagosklonny;Trends Pharmacol Sci,2005

2. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma;Leu;J Clin Oncol,2004

3. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel;Bradley;Clin Cancer Res,2001

4. Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile;Wolff;Clin Cancer Res,2003

5. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer;Banerjee;Cancer Res,2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth;Translational Oncology;2024-09

2. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics;Frontiers in Oncology;2024-07-15

3. Copper in Gynecological Diseases;International Journal of Molecular Sciences;2023-12-17

4. Strategies for the drug discovery and development of taxane anticancer therapeutics;Expert Opinion on Drug Discovery;2022-10-14

5. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer;Cells;2022-08-05